Treatment allocation bias

Slides:



Advertisements
Similar presentations
Observational Studies and RCT Libby Brewin. What are the 3 types of observational studies? Cross-sectional studies Case-control Cohort.
Advertisements

Study Designs in Epidemiologic
Making evidence more accessible using pictures
The Bahrain Branch of the UK Cochrane Centre In Collaboration with Reyada Training & Management Consultancy, Dubai-UAE Cochrane Collaboration and Systematic.
Joint Hospital Surgical Grand Round KL FOK NDH/AHNH Department of Surgery.
Biostatistics ~ Types of Studies. Research classifications Observational vs. Experimental Observational – researcher collects info on attributes or measurements.
Dr. Abdulaziz BinSaeed & Dr. Hayfaa A. Wahabi Department of Family & Community medicine  Case-Control Studies.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
 Be familiar with the types of research study designs  Be aware of the advantages, disadvantages, and uses of the various research design types  Recognize.
Intervention Studies Principles of Epidemiology Lecture 10 Dona Schneider, PhD, MPH, FACE.
Epidemiology The Basics Only… Adapted with permission from a class presentation developed by Dr. Charles Lynch – University of Iowa, Iowa City.
AETIOLOGY Case control studies (also RCT, cohort and ecological studies)
CHP400: Community Health Program- lI Research Methodology STUDY DESIGNS Observational / Analytical Studies Case Control Studies Present: Disease Past:
Sample Size Determination Donna McClish. Issues in sample size determination Sample size formulas depend on –Study design –Outcome measure Dichotomous.
Types of study designs Arash Najimi
1 Statin treatment is associated with improved prognosis in patients with AF-related stroke G. Ntaios, V. Papavasileiou, K.Makaritsis, A.Karagiannaki,
Lecture 6 Objective 16. Describe the elements of design of observational studies: (current) cohort studies (longitudinal studies). Discuss the advantages.
Bias Defined as any systematic error in a study that results in an incorrect estimate of association between exposure and risk of disease. To err is human.
Lecture 5 Objective 14. Describe the elements of design of experimental studies: clinical trials and community intervention trials. Discuss the advantages.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year.
Overview of Study Designs. Study Designs Experimental Randomized Controlled Trial Group Randomized Trial Observational Descriptive Analytical Cross-sectional.
Making epidemiological evidence more accessible using pictures Rod Jackson Updated November 09.
EVIDENCE BASED PRACTICE BY MOHEB KHOUZAM MD. EVIDENCE BASED PRACTICE  1- TYPES OF STUDY DESIGNS  2- RECOMMENDATIONS.
Symptom Distress During Breast Cancer Chemotherapy Does Race Matter? Margaret Quinn Rosenzweig, PhD, FNP-BC,AOCNP Associate Professor University of Pittsburgh.
Critical Appraisal (CA) I Prepared by Dr. Hoda Abd El Azim.
Lecture 5: The Natural History of Disease: Ways to Express Prognosis
Clinical Epidemiology and Evidence-based Medicine Unit FKUI – RSCM
Descriptive study design
Types of Studies. Aim of epidemiological studies To determine distribution of disease To examine determinants of a disease To judge whether a given exposure.
Levels of Evidence Dr Chetan Khatri Steering Committee, STARSurg.
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial Aron Goldhirsch, Richard.
Auditing Key Practice Indicators Workshop Henry Averns.
Journal Club Curriculum-Study designs. Objectives  Distinguish between the main types of research designs  Randomized control trials  Cohort studies.
Methods to Handle Noncompliance
Instructional Objectives:
Trials Adrian Boyle.
Savage KJ et al. Proc ASH 2015;Abstract 579.
Types of Research Studies Architecture of Clinical Research
Present: Disease Past: Exposure
Insights Using Data from California Richard H. White MD
Reducing bias in randomised controlled trials involving therapists:
Epidemiological Studies
Biostatistics Case Studies 2016
Donald E. Cutlip, MD Beth Israel Deaconess Medical Center
The Role of Statistics in Clinical Trials
Randomized Trials: A Brief Overview
Evidence-Based Medicine
Data Collection Principles
PALLIATIVE CARE T. Renaldi.
Challenges of statistical analysis in surgical trials
Some Epidemiological Studies
Presenter: Wen-Ching Lan Date: 2018/08/01
11/20/2018 Study Types.
Dr Jessica Jenkins Consultant Oncologist
Risk ratios 12/6/ : Risk Ratios 12/6/2018 Risk ratios StatPrimer.
Volume 149, Issue 4, Pages e12 (October 2015)
Epidemiology MPH 531 Analytic Epidemiology Case control studies
Candice Preslaski, PharmD, BCPS, BCCCP
Appraisal of an RCT using a critical appraisal checklist
Evidence Based Practice
Clinical/Medical Research Designs
Mohamed L. Sorror, MD, MSc ASH Oral presentation December 2018
Cohort Study.
Research process & study designs
Level of Evidence Lecture 4.
Lecture 21: Non-experimental intervention studies (cont)
THE LANCET Oncology Volume 19, No. 1, p27–39, January 2018
Basic statistics.
Presentation transcript:

Treatment allocation bias  Supplementary Table S2. Quality assessment tool Item Potential bias Signalling question Example 1 Selection bias Was there an absence of selection bias? i.e. was the spectrum of patients representative of those encountered in routine clinical practice? Examples where patients may be non-representative are specialist tertiary centres. Others may include screened versus non-screened patients, answer HIGH RISK of bias. Patients in trials are invariably highly selected, answer HIGH RISK of bias. If participants were recruited consecutively in routine practice, answer LOW RISK of bias. 2 Treatment allocation bias Was there an absence of treatment allocation bias? i.e. was treatment the same, independent of the exposure? If the study is an observational analysis within a RCT (of initial treatment), the treatment allocation has minimal bias (answer LOW RISK of bias). In almost all other examples, the answer is HIGH RISK of bias as there is potential for confounding by indication i.e. treatment allocation influenced by the exposure. If there were multiple treatments, answer HIGH RISK of bias. 3 Immortal time bias Was there absence of immortal time bias? i.e. did the investigators consider early mortality and relate this to the exposure? Immortal time refers to a period of follow-up during which, by design, death cannot occur; in this case, the period between baseline and follow-up weight measurements. This wait period is considered immortal because individuals who end up in the exposed (weight loss) group have to survive until the exposure definition is fulfilled. This biases the results by conferring a spurious survival advantage to the exposed group. If early mortality is accounted for, answer LOW RISK of bias. If early mortality is not discussed, answer UNCLEAR. 4 Additional treatment bias Was there an absence of additional treatment bias? Was selection for additional/ secondary treatments the same, independent of the exposure? If the study is an observational analysis within a RCT (of adjuvant therapy), the treatment allocation has minimal bias (answer LOW RISK of bias). In other studies the answer is usually HIGH RISK of bias, unless selection for adjuvant therapy was considered and found to be no different according to the exposure (e.g. proportion of patients receiving adjuvant chemotherapy no different across weight change categories). If multiple adjuvant therapies were used, answer as HIGH RISK of bias. 5 Adherence bias Was there absence of adherence or compliance bias? i.e. did the investigators consider adherence/ compliance to therapy (radiotherapy and chemotherapy) and relate these to the exposure? This may be reported among RCT follow-up; it is seldom reported in retrospective treatment series. If unreported, answer UNCLEAR. 6 Competing risk bias Was there absence of competing risk bias? Did the investigators consider non-cancer mortality, and relate this to the exposure? If the overall survival differs substantially from the cancer-specific survival, consider a competing risk of death bias. If only one of the survival types is reported, answer UNCLEAR (i.e. it was not considered).